Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study.
about
Molecular biology of breast tumors and prognosisManaging breast cancer in younger women: challenges and solutionsAn updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation.2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy.Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort studyBiology of breast cancer in young women.Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer.Comparison of Nottingham Prognostic Index and Adjuvant Online prognostic tools in young women with breast cancer: review of a single-institution experience.An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis.Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapyUS breast cancer mortality trends in young women according to raceTumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography.The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients.Lymphovascular space invasion and lack of downstaging after neoadjuvant chemotherapy are strong predictors of adverse outcome in young women with locally advanced breast cancerEthnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study.Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scoresObesity and the outcome of young breast cancer patients in the UK: the POSH study.Breast cancer under age 40: a different approach.Real-world impact of non-breast cancer-specific death on overall survival in resectable breast cancer.Nipple aspirate fluid-A liquid biopsy for diagnosing breast health.News on the medical treatment of young women with early-stage HER2-negative breast cancer.Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.Breast Cancer Metastasis Associations with Clinicopathological Characteristics in Mexican Women Younger than 40 Years of AgeBreast cancer in young women: an overview.Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer: The POSH Observational Cohort Study.Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screens.Family history and outcome of young patients with breast cancer in the UK (POSH study).MRI breast screening in high-risk women: cancer detection and survival analysis.Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women.Clinicopathologic and prognostic features of breast cancer in young women: a series from North of Morocco.Male breast cancer: a nation-wide population-based comparison with female breast cancer.Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.Analysis of breast cancer in young women in the Department of Defense (DOD) database.Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study.Development and External Validation of Prediction Models for 10-Year Survival of Invasive Breast Cancer. Comparison with PREDICT and CancerMath.Genetic testing in a cohort of young patients with HER2-amplified breast cancer.
P2860
Q26748546-1C6BF9C1-5FB7-4267-A22F-4F24C37FA8C4Q26771184-476CF2F3-98CA-41CA-8F2B-2F315CA60474Q33716808-C2D25E95-78D6-4CBE-8B78-0E03362D01D4Q33848895-21DE1F1D-37C6-4B03-B0D8-8451E69C0122Q33994275-22F91E97-65FA-4284-88E7-E09DB08978B5Q35000798-74105A47-6147-4C84-9ADC-AC0A0A08D8B6Q35020403-014C681C-105A-4BCD-8A14-6AF770E3ED48Q35046907-B43E46E6-F1F4-4E1E-9F0D-7F36A56E441DQ35198352-CA525BD5-98C4-4DF7-8623-9E1E05A92C36Q35218520-3E83A572-94D7-4BA1-AD8A-8B063B77C74DQ35536998-551C86B4-8D5D-497F-9E2A-440663433700Q35746459-5429E497-9730-45FE-9B7C-52D514D1F9DDQ35781316-D45EF856-7783-4694-8140-2568707103F2Q36528422-FB1577FB-89BF-49AC-A734-C753872FF7E7Q37459580-1C851B70-323D-4FFF-A80F-27E242F2195AQ37710182-23360B84-BBF0-4ADE-BFC6-00495FABD3AEQ38303253-74547AD4-605D-4161-9DEF-CC72B409C2D1Q38386346-83031FD8-6E6C-4958-BD04-BEF96E178534Q38749680-F1B8E79F-8541-4870-A126-A77E5F420442Q38794835-D87C4837-621B-467B-9DE6-04FB59C8A4AAQ38870541-E8C96070-A953-4900-8636-56F3B6FB92FBQ38968531-7BF915A3-9A9F-4F03-92F0-874F270B39E1Q39054166-E85F1A26-35DC-488B-B805-DEEE41759875Q39161921-1240C977-C389-4244-942E-217B4B5F6A94Q39562817-8000AE6B-E0BA-432E-B56D-66B653C8C22AQ40903518-CBB39B34-20A1-48D4-8E5C-D9863F518862Q40923313-4F441B2C-0679-494A-80C5-E97F60D61F9EQ45243016-D4879A8A-3DBB-4E72-B379-B95F31406B15Q45733546-34E27957-F0B8-4461-8D2B-342990CD96B9Q46301419-0F9C1BAE-8DB6-45E4-882A-C70E2EFDBA87Q47250831-95B59DDC-0195-422D-958F-CFA758C5A3DAQ47552886-95B7875E-2E99-426F-A096-2CE0990E7607Q47563898-6AE09FCF-702E-4FC7-94F2-C1BB8D87D8EDQ52642370-0B694250-CE1E-46B5-AF0D-5D482C68CBE2Q52695031-0281C896-D532-4E00-AA8E-7C776CB04384Q54227575-22125480-7A3B-4B75-936F-219EBCE5BF77
P2860
Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Prospective observational stud ...... at diagnosis: the POSH study.
@en
Prospective observational stud ...... at diagnosis: the POSH study.
@nl
type
label
Prospective observational stud ...... at diagnosis: the POSH study.
@en
Prospective observational stud ...... at diagnosis: the POSH study.
@nl
prefLabel
Prospective observational stud ...... at diagnosis: the POSH study.
@en
Prospective observational stud ...... at diagnosis: the POSH study.
@nl
P2093
P2860
P50
P356
P1476
Prospective observational stud ...... at diagnosis: the POSH study.
@en
P2093
Bryony Eccles
Ellen Copson
Gill Lawrence
Judith Bliss
Lorraine Durcan
Louise Jones
POSH Study Steering Group
Peter Simmonds
Ramsey I Cutress
P2860
P304
P356
10.1093/JNCI/DJT134
P407
P577
2013-05-30T00:00:00Z